Medical information Clinical review pending

Haematology Testing

FISH Aggressive Lymphoma Panel Test

The FISH Aggressive Lymphoma Panel Test uses advanced technology to detect specific genetic changes in lymphoma cells, aiding in diagnosis and treatment planning. Confirm with the laboratory before booking.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question

Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample: Formalin fixed paraffin embedded tissue block (must contain 10% tumor tissue) OR 4 mL (3 mL min.) whole blood OR 4 mL (2 mL min.) Bone Marrow from 1 Green Top (Sodium Heparin) tube.
Results: Confirm with the laboratory before booking.
Preparation: No specific patient preparation is required. Ensure the sample is collected and labelled correctly according to laboratory instructions. A duly filled Chromosome & FISH analysis Requisition Form (Form 17) is mandatory.

Test priceKSh 35,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the FISH Aggressive Lymphoma Panel Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

Insurer or scheme name & policy / member number
A clinician's request / prescription for the test
Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

Full name *

Mobile number *

+254

Insurer or scheme

Policy / member number (optional)

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

WhatsApp the claims team Call us

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

✓Suspected lymphoma diagnosis
✓Evaluation of known lymphoma
✓Unexplained swollen lymph nodes
✓Persistent fever, night sweats, or weight loss
✓Risk stratification for lymphoma
✓Guiding treatment decisions

In plain language

What this test helps you understand

This test helps identify specific genetic markers in lymphoma cells, which can influence treatment decisions, predict disease aggressiveness, and guide personalized therapy selection.

The FISH Aggressive Lymphoma Panel Test is an advanced diagnostic tool used in the evaluation of lymphomas. It utilizes Fluorescence In Situ Hybridization (FISH) technology to identify specific genetic abnormalities linked to aggressive forms of lymphoma. Detecting these changes helps healthcare providers make informed decisions about treatment strategies and patient care. This test looks for alterations in genes like BCL2, BCL6, and c-MYC, which provide crucial information about the lymphoma's behavior and potential aggressiveness. This information supports the development of tailored treatment plans. This test is often recommended for individuals with symptoms suggestive of lymphoma, such as unexplained weight loss, persistent fever, night sweats, or swollen lymph nodes. Patients already diagnosed with lymphoma or those considered high-risk may also benefit from this testing. The results help predict the lymphoma's aggressiveness and guide oncologists in selecting the most appropriate therapies, contributing to personalized medicine approaches.

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

Speak with us

We check the test and answer your questions before collection.

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

Understand your report

A counselor helps you understand the result and the next steps.

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →

PreparationNo specific patient preparation is required. Ensure the sample is collected and labelled correctly according to laboratory instructions. A duly filled Chromosome & FISH analysis Requisition Form (Form 17) is mandatory.

SampleFormalin fixed paraffin embedded tissue block (must contain 10% tumor tissue) OR 4 mL (3 mL min.) whole blood OR 4 mL (2 mL min.) Bone Marrow from 1 Green Top (Sodium Heparin) tube.

MethodologyFluorescence In Situ Hybridization (FISH)

PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.

This test detects specific genetic abnormalities but may not identify all possible genetic changes associated with lymphoma. Results must be interpreted in conjunction with clinical findings and other diagnostic tests. Confirm with the laboratory before booking.

Read your report

What common result terms mean

TermPlain-language meaning

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.

NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.

VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.

Questions people ask

Frequently asked questions

FISH (Fluorescence In Situ Hybridization) is a laboratory technique that uses fluorescent probes to detect specific DNA sequences within cells, helping identify genetic abnormalities.

This test helps identify genetic changes (like BCL2, BCL6, c-MYC alterations) that can affect how aggressive a lymphoma is and how it might respond to treatment.

The test can be performed on tissue samples (like from a biopsy), whole blood, or bone marrow. Your doctor will determine the best sample type.

A pathologist or geneticist interprets the results. Your doctor will discuss the findings with you in the context of your overall health and diagnosis.

This test helps characterize the type and potential aggressiveness of lymphoma but is usually part of a broader diagnostic process involving clinical evaluation and other tests.

Turnaround time varies. Please confirm the expected timeframe with the laboratory before booking.

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

ACMG/AMP technical standards for sequence variant interpretation
ClinGen curation and gene–disease validity frameworks where applicable
LOINC-coded reporting for interoperable results
ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

Last updated: September 27, 2026
Medical review: not yet completed
Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →

Chat on WhatsApp